CD40LG and cancer: Surprisingly, in a SARS-CoV-2 antibody seroprevalence study, performed by Cabezon-Gutierrez et al., high prevalence of IgG/IgM antibodies was detected in a relevant proportion of cancer patients (31,4%, 72/229 patients), mostly asymptomatic [42].